Last updated on October 2017

Immunogenicity and Tolerability of Broad Spectrum Human Papillomavirus (HPV) Vaccine in Adult and Young Adult Women (V503-004)


Brief description of study

This study will assess the safety and immunogenicity of GARDASIL®9 (V503) in 27- to 45-year-old women, and will complete the evaluation of GARDASIL®9 in the extended age range of female participants for whom GARDASIL® was proven to be effective. The primary hypothesis of the study states that anti-HPV 16, 18, 31, 33, 45, 52, and 58 titers at 4 weeks postdose 3 are non-inferior in adult women as compared with titers in young adult women.

Clinical Study Identifier: NCT03158220

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Study Coordinator

Universitatsklinik fuer Frauenheilkunde und Geburtshilfe ( Site 0002)
Graz, Austria
  Connect »

Study Coordinator

Klin. Abtlg. fuer Gynaekologie und Geburtshilfe ( Site 0001)
Wien, Austria
  Connect »

Study Coordinator

HUS Katiloopiston sairaala ( Site 0009)
Helsinki, Finland
  Connect »

Study Coordinator

Ita-Helsingin Rokotetutkimuskeskus ( Site 0011)
Helsinki, Finland
  Connect »

Study Coordinator

Porin Rokotetutkimusklinikka ( Site 0012)
Pori, Finland
  Connect »

Study Coordinator

Tampereen yliopisto - Tampereen rokotetutkimusklinikka ( Site 0010)
Tampere, Finland
  Connect »

Study Coordinator

Turun rokotetutkimusklinikka ( Site 0037)
Turku, Finland
  Connect »

Study Coordinator

Universitaetsmedizin Berlin Charite ( Site 0016)
Berlin, Germany
  Connect »

Study Coordinator

Universitaetsklinikum Duesseldorf ( Site 0014)
Dusseldorf, Germany
  Connect »

Study Coordinator

Praxis Dr. Peters ( Site 0015)
Hamburg, Germany
  Connect »

Study Coordinator

Universitaetsklinikum Hamburg-Eppendorf ( Site 0017)
Hamburg, Germany
  Connect »

Study Coordinator

Universitaetsklinikum Tuebingen ( Site 0013)
Tuebingen, Germany
  Connect »

Study Coordinator

Istituto Nazionale dei tumori ( Site 0020)
Milano, Italy
  Connect »

Study Coordinator

Ospedale San Raffaele ( Site 0022)
Milano, Italy
  Connect »

Study Coordinator

Azienda Ospedaliera Ospedali Riuniti Villa Sofia-Cervello ( Site 0023)
Palermo, Italy
  Connect »

Study Coordinator

CAP Centelles ( Site 0027)
Centelles, Spain
  Connect »

Study Coordinator

Institut Catala Oncologia de Bellvitge - ICO ( Site 0026)
Hospitalet de Llobregat, Spain
  Connect »

Study Coordinator

Hospital Sanitas La Moraleja ( Site 0031)
Madrid, Spain
  Connect »

Study Coordinator

Hospital Universitario Infanta Leonor ( Site 0028)
Madrid, Spain
  Connect »